Issue 11/2016 - Chemical giants at a glance

Lanxess' EBITDA in the ordinary business area amounted to €262 million in the first quarter of 2016, up by around 14 percent
compared to €229 million in the previous quarter.
Net profit increased significantly to 53 million euros
.
Following a good performance in the first quarter, the company raised its revenue forecast for fiscal 2016 and expects regular business-wide EBITDA to reach €900 million ~ €950 million for the current fiscal year, compared to the previous forecast of 880 million ~ 930 million euros
.


Clariant's sales from continuing operations in the first quarter of 2016 amounted to CHF 1,478 million, up 3 percent
in local currency.
The EBITDA ratio increased from 14.
1% to 15.
5%.

In 2016, the company will continue to improve cash flow from operating activities and EBITDA margin
before exceptions.


Celanese's adjusted earnings per share for the first quarter of 2016 were $1.
83, up 6%
year-over-year.
Adjusted earnings before interest and taxes (EBIT) were $358 million, with a margin of 25.
5%.

Free cash flow was $217 million
.


Eastman's first-quarter 2016 sales revenue fell $200 million year-over-year to $2.
2 billion
.
First-quarter operating income was $406 million, excluding non-core items, compared to $435 million in
the year-ago quarter.
Reported operating income was $399 million, compared to $311 million in
the same period last year.
Diluted earnings per share were $1.
71, excluding non-core items, compared to $
1.
84 in the first quarter of 2015.


Agilent Technology today announced revenue of $1.
02 billion for the fiscal second quarter ended April 30, 2016, up 6% from the year-ago quarter (up 8% on a currency-adjusted basis).

GAAP net income for the second quarter was $91 million, or $
0.
28 per diluted share.
Adjusted operating margin was 19.
4%, up 110 basis points
year-over-year.
In the second quarter of fiscal 2016, the company's operating income was $1.
02 billion, and core income increased 8%.